Report Detail
Global Retinal Disorders Drugs Market Insights, Forecast to 2025
- RnM3525733 |
- 14 June, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.
The global Retinal Disorders Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Retinal Disorders Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Retinal Disorders Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Retinal Disorders Drugs in these regions.
This research report categorizes the global Retinal Disorders Drugs market by top players/brands, region, type and end user. This report also studies the global Retinal Disorders Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Market size by Product
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Retinal Disorders Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Retinal Disorders Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Retinal Disorders Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Retinal Disorders Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Retinal Disorders Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Retinal Disorders Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Retinal Disorders Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Retinal Disorders Drugs Market Size Growth Rate by Product
- 1.4.2 Age Related Macular Degeneration
- 1.4.3 Diabetic Retinopathy
- 1.4.4 Ocular Inflammatory Disease (Uveitis)
- 1.4.5 Macular Hole
- 1.5 Market by End User
- 1.5.1 Global Retinal Disorders Drugs Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Retinal Disorders Drugs Market Size
- 2.1.1 Global Retinal Disorders Drugs Revenue 2014-2025
- 2.1.2 Global Retinal Disorders Drugs Sales 2014-2025
- 2.2 Retinal Disorders Drugs Growth Rate by Regions
- 2.2.1 Global Retinal Disorders Drugs Sales by Regions
- 2.2.2 Global Retinal Disorders Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Retinal Disorders Drugs Sales by Manufacturers
- 3.1.1 Retinal Disorders Drugs Sales by Manufacturers
- 3.1.2 Retinal Disorders Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Retinal Disorders Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Retinal Disorders Drugs Revenue by Manufacturers
- 3.2.1 Retinal Disorders Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Retinal Disorders Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Retinal Disorders Drugs Price by Manufacturers
- 3.4 Retinal Disorders Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Retinal Disorders Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Retinal Disorders Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Retinal Disorders Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Retinal Disorders Drugs Sales by Product
- 4.2 Global Retinal Disorders Drugs Revenue by Product
- 4.3 Retinal Disorders Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Retinal Disorders Drugs Breakdown Data by End User
6 North America
- 6.1 North America Retinal Disorders Drugs by Countries
- 6.1.1 North America Retinal Disorders Drugs Sales by Countries
- 6.1.2 North America Retinal Disorders Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Retinal Disorders Drugs by Product
- 6.3 North America Retinal Disorders Drugs by End User
7 Europe
- 7.1 Europe Retinal Disorders Drugs by Countries
- 7.1.1 Europe Retinal Disorders Drugs Sales by Countries
- 7.1.2 Europe Retinal Disorders Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Retinal Disorders Drugs by Product
- 7.3 Europe Retinal Disorders Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Retinal Disorders Drugs by Countries
- 8.1.1 Asia Pacific Retinal Disorders Drugs Sales by Countries
- 8.1.2 Asia Pacific Retinal Disorders Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Retinal Disorders Drugs by Product
- 8.3 Asia Pacific Retinal Disorders Drugs by End User
9 Central & South America
- 9.1 Central & South America Retinal Disorders Drugs by Countries
- 9.1.1 Central & South America Retinal Disorders Drugs Sales by Countries
- 9.1.2 Central & South America Retinal Disorders Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Retinal Disorders Drugs by Product
- 9.3 Central & South America Retinal Disorders Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Retinal Disorders Drugs by Countries
- 10.1.1 Middle East and Africa Retinal Disorders Drugs Sales by Countries
- 10.1.2 Middle East and Africa Retinal Disorders Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Retinal Disorders Drugs by Product
- 10.3 Middle East and Africa Retinal Disorders Drugs by End User
11 Company Profiles
- 11.1 ALLERGAN
- 11.1.1 ALLERGAN Company Details
- 11.1.2 Company Business Overview
- 11.1.3 ALLERGAN Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 ALLERGAN Retinal Disorders Drugs Products Offered
- 11.1.5 ALLERGAN Recent Development
- 11.2 AbbVie
- 11.2.1 AbbVie Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AbbVie Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AbbVie Retinal Disorders Drugs Products Offered
- 11.2.5 AbbVie Recent Development
- 11.3 Alimera Sciences
- 11.3.1 Alimera Sciences Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Alimera Sciences Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Alimera Sciences Retinal Disorders Drugs Products Offered
- 11.3.5 Alimera Sciences Recent Development
- 11.4 Janssen Biotech
- 11.4.1 Janssen Biotech Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Janssen Biotech Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Janssen Biotech Retinal Disorders Drugs Products Offered
- 11.4.5 Janssen Biotech Recent Development
- 11.5 Swedish Orphan Biovitrum
- 11.5.1 Swedish Orphan Biovitrum Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Swedish Orphan Biovitrum Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Swedish Orphan Biovitrum Retinal Disorders Drugs Products Offered
- 11.5.5 Swedish Orphan Biovitrum Recent Development
- 11.6 Roche
- 11.6.1 Roche Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Roche Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Roche Retinal Disorders Drugs Products Offered
- 11.6.5 Roche Recent Development
- 11.7 Bristol-Myers Squibb
- 11.7.1 Bristol-Myers Squibb Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bristol-Myers Squibb Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bristol-Myers Squibb Retinal Disorders Drugs Products Offered
- 11.7.5 Bristol-Myers Squibb Recent Development
- 11.8 Genzyme
- 11.8.1 Genzyme Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Genzyme Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Genzyme Retinal Disorders Drugs Products Offered
- 11.8.5 Genzyme Recent Development
- 11.9 Genentech
- 11.9.1 Genentech Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Genentech Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Genentech Retinal Disorders Drugs Products Offered
- 11.9.5 Genentech Recent Development
- 11.10 OCULAR THERAPEUTIX
- 11.10.1 OCULAR THERAPEUTIX Company Details
- 11.10.2 Company Business Overview
- 11.10.3 OCULAR THERAPEUTIX Retinal Disorders Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 OCULAR THERAPEUTIX Retinal Disorders Drugs Products Offered
- 11.10.5 OCULAR THERAPEUTIX Recent Development
- 11.11 Bausch & Lomb
- 11.12 UCBCares
12 Future Forecast
- 12.1 Retinal Disorders Drugs Market Forecast by Regions
- 12.1.1 Global Retinal Disorders Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Retinal Disorders Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Retinal Disorders Drugs Market Forecast by Product
- 12.2.1 Global Retinal Disorders Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Retinal Disorders Drugs Revenue Forecast by Product 2019-2025
- 12.3 Retinal Disorders Drugs Market Forecast by End User
- 12.4 North America Retinal Disorders Drugs Forecast
- 12.5 Europe Retinal Disorders Drugs Forecast
- 12.6 Asia Pacific Retinal Disorders Drugs Forecast
- 12.7 Central & South America Retinal Disorders Drugs Forecast
- 12.8 Middle East and Africa Retinal Disorders Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Retinal Disorders Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Retinal Disorders Drugs. Industry analysis & Market Report on Retinal Disorders Drugs is a syndicated market report, published as Global Retinal Disorders Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Retinal Disorders Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
